Viatris makes progress on Ozempic patent challenge : vimarsa

Board agrees to review patent covering certain strengths of blockbuster diabetes drug

Related Keywords

, Mylan Pharmaceuticals , Novo Nordisk , Trademark Office , Article Normal , Pharmaceuticals , Healthcare Life Sciences , Generic Biosimilar Drugs , Regulation Government Policy , Patents , New Products Services , Research Development , Product Service Approvals , Corporate Industrial News , Products Services , Intellectual Property Rights , Industrial Property Rights , New Product Service Testing , Political General News , Diabetes , Health , Medical Conditions , Content Types , Factiva Filters , C Amp Ampe Industry News Filter , Novo Nordiskas Adr , Nvo , Viatris Inc , Vtrs , Regulation , Government Policy , New Products , Services , Research , Development , Product , Service Approvals , Corporate , Industrial News , Products , New Product , Service Testing , Political , General News , Healthcare , Life Sciences , Generic , Biosimilar Drugs ,